Correlation Between Nuvalent and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Ultragenyx, you can compare the effects of market volatilities on Nuvalent and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Ultragenyx.
Diversification Opportunities for Nuvalent and Ultragenyx
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nuvalent and Ultragenyx is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Nuvalent i.e., Nuvalent and Ultragenyx go up and down completely randomly.
Pair Corralation between Nuvalent and Ultragenyx
Given the investment horizon of 90 days Nuvalent is expected to generate 0.86 times more return on investment than Ultragenyx. However, Nuvalent is 1.17 times less risky than Ultragenyx. It trades about -0.01 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.32 per unit of risk. If you would invest 9,371 in Nuvalent on August 24, 2024 and sell it today you would lose (98.00) from holding Nuvalent or give up 1.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nuvalent vs. Ultragenyx
Performance |
Timeline |
Nuvalent |
Ultragenyx |
Nuvalent and Ultragenyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvalent and Ultragenyx
The main advantage of trading using opposite Nuvalent and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |